Northwell Health: Schizophrenia trials
The registry lists 30 Schizophrenia studies with Northwell Health as lead sponsor. 5 are open to participants now and 11 have results posted.
Phase 1 1Phase 2 1Phase 4 7No phase 22(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- MicroRNAs as Biomarkers in First Episode SchizophreniaRecruitingNCT07703670Not applicable
- Biomarkers to Enhance Early Schizophrenia TreatmentRecruitingNCT06969755Phase 4
- iTBS to Enhance Social Cognition in People With PsychosisRecruitingNCT06118268Not applicable
- Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot StudyRecruitingNCT05389787Not applicable
- Early-Phase Schizophrenia: Practice-based Research to Improve OutcomesRecruitingNCT04004364
- Using Digital Media Advertising to Reduce the Duration of Untreated PsychosisCompletedNCT03975400Not applicableResults posted
- Boost rTMS for Auditory Verbal HallucinationsTerminatedNCT03544333Not applicableResults posted
- The Effect of Transcranial Direct Current Stimulation on Human Brains: A Neuroimaging StudyCompletedNCT02421146Not applicableResults posted
- An Integrated Program for the Treatment of First Episode of PsychosisCompletedNCT01321177Not applicableResults posted
- Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for SchizophreniaTerminatedNCT00794963Not applicableResults posted
- Improving Medication Adherence Among People With Schizophrenia Through the Use of 2-way PagersCompletedNCT00392236Not applicableResults posted
- Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating EfficacyCompletedNCT00330863Phase 4Results posted
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode PsychosisCompletedNCT00320671Phase 4Results posted
- Optimizing Response in Psychosis StudyTerminatedNCT00314327Phase 4Results posted
- Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine BlockadeCompletedNCT00225498Not applicableResults posted
- Electroconvulsive Therapy in Clozapine Refractory SchizophreniaCompletedNCT00042224Phase 1/2Results posted
- Ascertaining Diagnosis Classification With Elicited SpeechCompletedNCT05601063
- Linguistic Predictors of Outcomes in PsychosisCompletedNCT05601050
- Financial Incentives to Improve Medication AdherenceCompletedNCT04191876Not applicable
- Transcranial Direct Current Stimulation for Hallucinations in First-Episode SchizophreniaWithdrawnNCT02661347Not applicable
- Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase PsychosisCompletedNCT02566057Not applicable
- Improving Care and Reducing Cost StudyCompletedNCT02364544Not applicable
- Adjunctive Vortioxetine in SchizophreniaActive, not recruitingNCT02357797Phase 4
- Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With PsychosisCompletedNCT01878513Not applicable
- Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics.CompletedNCT01786369
- Clinical Risk State for Bipolar Disorder in AdolescentsStatus unknownNCT01383915
- Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative SymptomsCompletedNCT00169988Not applicable
- Aripiprazole Treatment of the ProdromeTerminatedNCT00169949Not applicable
- Treating Drug-Resistant Childhood SchizophreniaCompletedNCT00048828Phase 4
- Treatment for First-Episode SchizophreniaCompletedNCT00000374Phase 4